This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.  Read our Cookies Policy.
Close
Eye News
  • Features
    • Close
    • Features
    • Allied Professions
    • Humanitarian
    • Interviews
    • AI & Oculomics
    • Ophthalmology
    • Optometry
    • Podcast videos
    • Supplements
  • Education
    • Close
    • Education
    • Learning Curve
    • Quiz
    • Top Tips
    • Trainees
    • Medico-Legal
    • The Truth Behind The Headlines
    • Case Reports
    • Pete's Bogus Journey
  • Reviews
    • Close
    • Reviews
    • Book Reviews
    • Journal Reviews
    • What's trending?
    • Tech Reviews
    • My Top Five
    • The Culture Section
  • Events
  • News
  • Product Guide
  • Industry News
  • Contact us
    • Close
    • Contact us
    • Write for Eye News
  • Home
  • Reviews
  • Journal Reviews
  • Cytokine levels in vitreous fluid in patients with pathological myopia

Cytokine levels in vitreous fluid in patients with pathological myopia
Reviewed by Kurt Spiteri Cornish

1 April 2020 | Kurt Spiteri Cornish | EYE - Vitreo-Retinal
Share This

Pathological myopia (PM) is a leading cause of irreversible visual impairment worldwide, and efforts are dedicated to the study of its underlying mechanisms. Axial extension of the eyeball is regulated via a cascade of biochemical molecules that are initiated in the retina or choroid, causing scleral extracellular matrix (ECM) remodelling. Wnt/β-catenin signalling pathway is a growth control pathway that affects cell proliferation and architecture maintenance. Dickkopf-1 (DKK1) is a protein that antagonises this pathway and therefore regulates fibrosis and deposition of ECM molecules. Evidence has shown that gene therapy with DKK1 could suppress collagen accumulation and release of ECM in heart, renal and liver fibrosis. However, the possible roles of DKK1 in myopia are still poorly understood. The authors of this study evaluated DKK1 levels in the vitreous of 136 patients with no myopia, low to moderate myopia and PM and sought to explore the relationship with axial length, choroidal thickness and other cytokines. The intravitreous levels of DKK1 and matrix metalloproteinase-2 (MMP-2) were much higher in patients with PM than the other two groups. Other cytokines showed no obvious differences. There was also a close association between DKK1 levels and axial length, as well as subfoveal choroidal thickness (SFCT). The biomechanical properties of the sclera are dependent on composition of the ECM and remodelling of the sclera is under control of a specific cascade of biochemical events that are initially located in the retina, including DKK1. This study supports the hypothesis that altered biochemical factors in the intraocular fluids may be a reflection of retina-derived regulation of scleral remodelling through the release of molecules that could degrade various components of ECM, which leads to axial elongation in highly myopic eyes.

Increased levels of DKK1 in vitreous fluid of patients with pathological myopia and the correlation between DKK1 levels and axial length.
Peng M, Wei Y, Zhang Z, et al.
CURRENT EYE RESEARCH
2020;45(1):104-10.
Share This
CONTRIBUTOR
Kurt Spiteri Cornish

Sheffield Teaching Hospitals NHS Trust, London, UK.

View Full Profile
Specialty
  • EYE - Cataract
  • EYE - Cornea
  • EYE - General
  • EYE - Glaucoma
  • EYE - Neuro-ophthalmology
  • EYE - Oculoplastic
  • EYE - Oncology
  • EYE - Orbit
  • EYE - Paediatrics
  • EYE - Pathology
  • EYE - Refractive
  • EYE - Strabismus
  • EYE - Vitreo-Retinal
Archive
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013

Top Of Page

9 Gayfield Square, 
Edinburgh EH1 3NT, UK.

Call: +44 (0)131 557 4184
www.pinpoint-scotland.com

WEBSITE DETAILS
  • Cookie Policy
  • Data Protection Notice
  • Privacy Policy
  • Terms and Conditions
ABOUT US
  • Who we are
  • Register
  • Contact us
  • Contributors
  • Company Awards
DIGITAL ISSUES/GUIDELINES
  • Digital issues - Library
  • Supplements - Library
  • Guidelines
Accreditations
IPSO_FLAG_TEAL 2025.png cpdcertified.png

Pinpoint Scotland Ltd (Registered in Scotland No. SC068684) | © 2025 - Website by Gecko Agency